"Lupin" の関連情報検索結果

Lupin Completes Acquisition of VISUfarma - PR Newswire



Lupin Completes Acquisition of VISUfarma  PR Newswire

Lupin Limited: Acquisition Of VISUfarma Expands European Ophthalmology Portfolio - Pulse 2.0



Lupin Limited: Acquisition Of VISUfarma Expands European Ophthalmology Portfolio  Pulse 2.0

Lupin Completes Acquisition of VISUfarma to Strengthen European Specialty Portfolio - Machine Maker



Lupin Completes Acquisition of VISUfarma to Strengthen European Specialty Portfolio  Machine Maker

LUPIN THE IIIRD: The Movie - The Immortal Bloodline Blu-ray Release Dated - Crunchyroll



LUPIN THE IIIRD: The Movie - The Immortal Bloodline Blu-ray Release Dated  Crunchyroll

Lupin III: Green vs. Red (2008) - IMDb



Lupin III: Green vs. Red (2008)  IMDb

Netflix's 3-Part Heist Thriller Is the Perfect Weekend Binge Before Its 2026 Return - Collider



Netflix's 3-Part Heist Thriller Is the Perfect Weekend Binge Before Its 2026 Return  Collider

Lupin - Receives Tentative Approval From U.S. FDA For Sugammadex Injection - TradingView



Lupin - Receives Tentative Approval From U.S. FDA For Sugammadex Injection  TradingView

Lupin Announces New U.S. Manufacturing Facility and $250 Million Domestic Investment - Associatio...



Lupin Announces New U.S. Manufacturing Facility and $250 Million Domestic Investment  Association for Accessible Medicines

Lupin Subsidiary Acquires 43.38% Stake In Multicare Pharmaceutical Company - BW Healthcare World



Lupin Subsidiary Acquires 43.38% Stake In Multicare Pharmaceutical Company  BW Healthcare World

India's Zydus, Lupin sign deal to co‑market Semaglutide injections - Reuters



India's Zydus, Lupin sign deal to co‑market Semaglutide injections  Reuters

Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in Ind...



Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India  lupin.com

‘Lupin’ Part 4 Sets Fall 2026 Release on Netflix - Variety



‘Lupin’ Part 4 Sets Fall 2026 Release on Netflix  Variety

India's Zydus, Lupin sign deal to co‑market Semaglutide injections - Yahoo Finance



India's Zydus, Lupin sign deal to co‑market Semaglutide injections  Yahoo Finance

Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla. ...



Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla.  Fierce Pharma

Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets - PR Newswire



Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets  PR Newswire

India's Lupin settles US patent dispute with Astellas Pharma for $90 million - Reuters



India's Lupin settles US patent dispute with Astellas Pharma for $90 million  Reuters

Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from ...



Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital  PR Newswire

Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusi...



Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform  PR Newswire

Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Fl...



Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Florida Extending its Long-Standing Commitment to America's Patients and Healthcare System  PR Newswire

Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions - Ophthalmolog...



Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions  Ophthalmology Times Europe

Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Security - PR Newswire



Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Security  PR Newswire

Lupin’s VISUfarma Buy Adds Ophthalmology Scale—But Integration Risks Could Drag on Execution - Bi...



Lupin’s VISUfarma Buy Adds Ophthalmology Scale—But Integration Risks Could Drag on Execution  Bitget

Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business ...



Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans  PR Newswire

‘Lupin’ Part 4 Gets Premiere Window At Netflix - Deadline



‘Lupin’ Part 4 Gets Premiere Window At Netflix  Deadline

Lupin the IIIrd the Movie: The Immortal Bloodline review – eye-popping fan-service in latest in a...



Lupin the IIIrd the Movie: The Immortal Bloodline review – eye-popping fan-service in latest in anime franchise  The Guardian

Lupin Expands European Footprint with VISUfarma Acquisition - devdiscourse.com



Lupin Expands European Footprint with VISUfarma Acquisition  devdiscourse.com

Lupin eyes US growth through targeted drug launches - CNBC



Lupin eyes US growth through targeted drug launches  CNBC

Lupin completes acquisition of VISUfarma - Business Standard



Lupin completes acquisition of VISUfarma  Business Standard

Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor...



Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist  lupin.com

Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries - Lupin | P...



Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries - Lupin | Press Release  lupin.com

Lupin completes acquisition of VISUfarma to boost European eye care portfolio - BusinessLine



Lupin completes acquisition of VISUfarma to boost European eye care portfolio  BusinessLine

Lupin arm to acquire 43.38% stake in Multicare Pharmaceuticals Philippines for US $39.6 m - CNBC ...



Lupin arm to acquire 43.38% stake in Multicare Pharmaceuticals Philippines for US $39.6 m  CNBC TV18

Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant Desla...



Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex™ in Canada - Lupin | Press Release  lupin.com

Lupin’s Goa facility inspection concluded by US FDA without any observations - Lupin | Press Rele...



Lupin’s Goa facility inspection concluded by US FDA without any observations - Lupin | Press Release  lupin.com

'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai...



'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai  PR Newswire

Lupin launches generic Clobetasol Propionate Ointment USP 0.05% in the US - Lupin | Press Release...



Lupin launches generic Clobetasol Propionate Ointment USP 0.05% in the US - Lupin | Press Release  lupin.com

Lupin III: The Castle of Cagliostro (1979) - IMDb



Lupin III: The Castle of Cagliostro (1979)  IMDb

#SpeakPharma with Dr. Abdelaziz Toumi, CEO – Lupin Manufacturing Solutions (LMS) - Lupin | Perspe...



#SpeakPharma with Dr. Abdelaziz Toumi, CEO – Lupin Manufacturing Solutions (LMS) - Lupin | Perspective  lupin.com

Lupin (2021) - IMDb



Lupin (2021)  IMDb

Lupin Receives Approval for Generic Albuterol Sulphate MDI - Lupin | Press Release - lupin.com



Lupin Receives Approval for Generic Albuterol Sulphate MDI - Lupin | Press Release  lupin.com

Lupin III: Part III (1984) - IMDb



Lupin III: Part III (1984)  IMDb

Lupin Manufacturing Solutions Announces Expansion of Manufacturing Facility at Dabhasa, India - l...



Lupin Manufacturing Solutions Announces Expansion of Manufacturing Facility at Dabhasa, India  lupin.com

Lupin season 4 release window finally confirmed by Netflix as beloved series to return - Radio Times



Lupin season 4 release window finally confirmed by Netflix as beloved series to return  Radio Times

Lupin Part 4 Will Arrive in Fall 2026 - Netflix



Lupin Part 4 Will Arrive in Fall 2026  Netflix

Lupin Receives FDA Approval for Generic Percocet® Tablets - Lupin | Press Release - lupin.com



Lupin Receives FDA Approval for Generic Percocet® Tablets - Lupin | Press Release  lupin.com

12 stocks to watch on April 2: Wipro, IndiGo, Lupin, Glenmark, AGI Infra, Aavas Financier - Busin...



12 stocks to watch on April 2: Wipro, IndiGo, Lupin, Glenmark, AGI Infra, Aavas Financier  BusinessLine

Netflix's 3-Part Crime Thriller Series Is One Of Its Best - ScreenRant



Netflix's 3-Part Crime Thriller Series Is One Of Its Best  ScreenRant

Lupin shares down 2% as arm to acquire 43.38% stake in Multicare Pharma - Moneycontrol.com



Lupin shares down 2% as arm to acquire 43.38% stake in Multicare Pharma  Moneycontrol.com

Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP - Lupin | Press...



Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP - Lupin | Press Release  lupin.com

Lupin Announces Achievement of Key Milestones for its Clinical Stage MEK Inhibitor Compound - Lup...



Lupin Announces Achievement of Key Milestones for its Clinical Stage MEK Inhibitor Compound - Lupin | Press Release  lupin.com

Lupin unit Nanomi to acquire remaining 43.38% stake in Philippines arm for up to $39.6 million - ...



Lupin unit Nanomi to acquire remaining 43.38% stake in Philippines arm for up to $39.6 million  CNBC TV18

Lupin the IIIrd: The Movie – The Immortal Bloodline — Takeshi Koike [Review] - In Review Online



Lupin the IIIrd: The Movie – The Immortal Bloodline — Takeshi Koike [Review]  In Review Online

Lupin Receives European Commission Approval for Biosimilar Ranibizumab - Lupin | Press Release - ...



Lupin Receives European Commission Approval for Biosimilar Ranibizumab - Lupin | Press Release  lupin.com

Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First P...



Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - Lupin | Press Release  lupin.com

Lupin the Third: Jigen's Gravestone (2014) - IMDb



Lupin the Third: Jigen's Gravestone (2014)  IMDb

Lupin Acquires Symbiomix Therapeutics LLC - Lupin | Press Release - lupin.com



Lupin Acquires Symbiomix Therapeutics LLC - Lupin | Press Release  lupin.com

Dr. Desh Bandhu Gupta, Founder and Chairman of Lupin passes away - Lupin | Press Release - lupin.com



Dr. Desh Bandhu Gupta, Founder and Chairman of Lupin passes away - Lupin | Press Release  lupin.com

Lupin Completes its Acquisition of GAVIS - Lupin | Press Release - lupin.com



Lupin Completes its Acquisition of GAVIS - Lupin | Press Release  lupin.com

Lupin Bioresearch Centre completes fifth successful U.S. FDA inspection - Lupin | Press Release -...



Lupin Bioresearch Centre completes fifth successful U.S. FDA inspection - Lupin | Press Release  lupin.com

Lupin enters into agreement to divest its stake in Kyowa to Unison - Lupin | Press Release - lupi...



Lupin enters into agreement to divest its stake in Kyowa to Unison - Lupin | Press Release  lupin.com

Lupin Launches Liraglutide Injection in the United States - Lupin | Press Release - lupin.com



Lupin Launches Liraglutide Injection in the United States - Lupin | Press Release  lupin.com

Lupin Announces Launch of Orphan Drug NaMuscla® in Germany and the UK for the Treatment of Myoton...



Lupin Announces Launch of Orphan Drug NaMuscla® in Germany and the UK for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders - Lupin | Press Release  lupin.com

Lupin’s Pithampur Unit-3 (Indore) receives EIR from U.S. FDA - Lupin | Press Release - lupin.com



Lupin’s Pithampur Unit-3 (Indore) receives EIR from U.S. FDA - Lupin | Press Release  lupin.com

Lupin appoints Alok Sonig as CEO – US Generics and Global Head – Generics R&D & Biosimilars - lup...



Lupin appoints Alok Sonig as CEO – US Generics and Global Head – Generics R&D & Biosimilars  lupin.com

Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from ...



Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital  lupin.com

FDA Approves Lupin’s Generic Tolvaptan Tablets - docwirenews.com



FDA Approves Lupin’s Generic Tolvaptan Tablets  docwirenews.com

Lupin receives FDA approval for generic Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 10...



Lupin receives FDA approval for generic Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg  lupin.com

Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025...



Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025  lupin.com

Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskusi...



Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskusi®  lupin.com

Lupin Shares Slumped Despite Acquiring Stake in Multicare Pharma - Equitypandit



Lupin Shares Slumped Despite Acquiring Stake in Multicare Pharma  Equitypandit

Netflix drops Lupin season 4 update – but fans are 'crying' over the wait - hellomagazine.com



Netflix drops Lupin season 4 update – but fans are 'crying' over the wait  hellomagazine.com

Lupin enters dermatology segment in Brazil with launch of Lupin High-End Skin Science - Lupin | P...



Lupin enters dermatology segment in Brazil with launch of Lupin High-End Skin Science - Lupin | Press Release  lupin.com

Lupin Launches Atorvastatin Calcium Tablets USP - Lupin | Press Release - lupin.com



Lupin Launches Atorvastatin Calcium Tablets USP - Lupin | Press Release  lupin.com

Lupin receives FDA approval for generic Kapvay® Extended-Release Tablets - Lupin | Press Release ...



Lupin receives FDA approval for generic Kapvay® Extended-Release Tablets - Lupin | Press Release  lupin.com

Lupin Q3 FY2026 Results - Lupin | Press Release - lupin.com



Lupin Q3 FY2026 Results - Lupin | Press Release  lupin.com

Lupin Receives EIR from US FDA for its Goa Facility - Lupin | Press Release - lupin.com



Lupin Receives EIR from US FDA for its Goa Facility - Lupin | Press Release  lupin.com

Lupin Bioresearch Center Receives Zero Observations from U.S. FDA After Successful Inspection and...



Lupin Bioresearch Center Receives Zero Observations from U.S. FDA After Successful Inspection and Assessment  lupin.com

‘Lupin’ Season 4 Wraps Filming for Netflix; Confirmed for 2026 Release - What's on Netflix



‘Lupin’ Season 4 Wraps Filming for Netflix; Confirmed for 2026 Release  What's on Netflix

Lupin Acquires Specialty Product Portfolio in Germany - Lupin | Press Release - lupin.com



Lupin Acquires Specialty Product Portfolio in Germany - Lupin | Press Release  lupin.com

Lupin Receives Approval from U.S. FDA for Tolvaptan Tablets - Lupin | Press Release - lupin.com



Lupin Receives Approval from U.S. FDA for Tolvaptan Tablets - Lupin | Press Release  lupin.com

Lupin and Eli Lilly Expand Partnership in India - Lupin | Press Release - lupin.com



Lupin and Eli Lilly Expand Partnership in India - Lupin | Press Release  lupin.com

Lupin receives FDA approval for Nikita™ (Pitavastatin) Tablets - Lupin | Press Release - lupin.com



Lupin receives FDA approval for Nikita™ (Pitavastatin) Tablets - Lupin | Press Release  lupin.com

Lupins in the genome editing era: advances in plant cell culture, double haploid technology and g...



Lupins in the genome editing era: advances in plant cell culture, double haploid technology and genetic transformation for crop improvement  Frontiers

Great Adaptations: Lupin on screen - globalcomment.com



Great Adaptations: Lupin on screen  globalcomment.com

Lupin receives FDA approval for Lamotrigine tablets - Lupin | Press Release - lupin.com



Lupin receives FDA approval for Lamotrigine tablets - Lupin | Press Release  lupin.com

‘Lupin’ Returning for Season 4 - The Hollywood Reporter



‘Lupin’ Returning for Season 4  The Hollywood Reporter

The unexplored diversity of rough-seeded lupins provides rich genomic resources and insights into...



The unexplored diversity of rough-seeded lupins provides rich genomic resources and insights into lupin evolution  Nature

"A near-perfect mystery thriller": Netflix megahit Lupin makes "surprise" return for "extraordina...



"A near-perfect mystery thriller": Netflix megahit Lupin makes "surprise" return for "extraordinary" series 4  Good Housekeeping

Lupin Completes Acquisition of VISUfarma B.V. Through Netherlands Subsidiary - scanx.trade



Lupin Completes Acquisition of VISUfarma B.V. Through Netherlands Subsidiary  scanx.trade

Lupin launches Solosec™ (secnidazole) 2g Oral Granules in the US - Lupin | Press Release - lupin.com



Lupin launches Solosec™ (secnidazole) 2g Oral Granules in the US - Lupin | Press Release  lupin.com

Lupin Secures USFDA Tentative Approval for Pitolisant Tablets, Expands CNS Portfolio - eHealth Ma...



Lupin Secures USFDA Tentative Approval for Pitolisant Tablets, Expands CNS Portfolio  eHealth Magazine

Lupin goes for bigger bites of innovation - BusinessLine



Lupin goes for bigger bites of innovation  BusinessLine

Lupin’s Aurangabad Facility Receives EIR from U.S. FDA - Lupin | Press Release - lupin.com



Lupin’s Aurangabad Facility Receives EIR from U.S. FDA - Lupin | Press Release  lupin.com

‘Lupin 4’ Confirmed By Netflix As Shoot With Omar Sy Begins In Paris - Deadline



‘Lupin 4’ Confirmed By Netflix As Shoot With Omar Sy Begins In Paris  Deadline

Lupin Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets - Lupin | Press ...



Lupin Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets - Lupin | Press Release  lupin.com

The ₹40-crore AI payoff: How Lupin is building a data-first, AI-ready pharma enterprise - Lupin |...



The ₹40-crore AI payoff: How Lupin is building a data-first, AI-ready pharma enterprise - Lupin | Perspective  lupin.com

'Lupin' Season 4: First Look at Omar Sy Action Sequence in Paris as Filming Comes To A Close - Wh...



'Lupin' Season 4: First Look at Omar Sy Action Sequence in Paris as Filming Comes To A Close  What's on Netflix

Lupin Launches Leflunomide Tablets USP - Lupin | Press Release - lupin.com



Lupin Launches Leflunomide Tablets USP - Lupin | Press Release  lupin.com

Netflix Confirms Season 4 Return of Hit 98% RT Crime Thriller - Collider



Netflix Confirms Season 4 Return of Hit 98% RT Crime Thriller  Collider

Lupin Receives Tentative Approval for Empagliflozin Tablets - Lupin | Press Release - lupin.com



Lupin Receives Tentative Approval for Empagliflozin Tablets - Lupin | Press Release  lupin.com